Page last updated: 2024-11-05

tetraethylammonium and Osteogenic Sarcoma

tetraethylammonium has been researched along with Osteogenic Sarcoma in 3 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pelagalli, A1
Nardelli, A1
Fontanella, R1
Zannetti, A1
Kawase, T1
Burns, DM1
Richter, C1
Ferrier, J1

Other Studies

3 other studies available for tetraethylammonium and Osteogenic Sarcoma

ArticleYear
Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
    International journal of molecular sciences, 2016, Jul-11, Volume: 17, Issue:7

    Topics: Aquaporin 1; Bone Marrow Cells; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Mo

2016
Calcitonin gene-related peptide stimulates potassium efflux through adenosine triphosphate-sensitive potassium channels and produces membrane hyperpolarization in osteoblastic UMR106 cells.
    Endocrinology, 1998, Volume: 139, Issue:8

    Topics: Adenosine Triphosphate; Animals; Calcitonin Gene-Related Peptide; Colforsin; Enzyme Inhibitors; Glyb

1998
Continuously active sodium channels in osteoblastic ROS 17/2.8 cells.
    Bone and mineral, 1991, Volume: 15, Issue:1

    Topics: Animals; Calcium; Conductometry; Membrane Potentials; Nifedipine; Osteoblasts; Osteosarcoma; Rats; S

1991